Role of the HIV-1 matrix protein in Gag intracellular trafficking and targeting to the plasma membrane for virus assembly

Frontiers in Microbiology

Volumn 3, Issue FEB, 2012, Pages

  Ghanam, Ruba H ^a   Samal, Alexandra B ^a   Fernandez, Timothy F ^a   Saad, Jamil S ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

Assembly; Gag; Matrix; Myristyl; NMR; Plasma membrane; Trafficking

Indexed keywords

EID: 84868138485     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2012.00055     Document Type: Article

References (195)

1. Adamson, C. S., and Freed, E. O. (2007). Human immunodeficiency virus type 1 assembly, release and maturation. Adv. Pharmacol. 55, 347-387.
2. Akari, H., Fukumori, T., and Adachi, A. (2000). Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env incorporation into virions. J. Virol. 74, 4891-4893.
3. Alfadhli, A., Barklis, R. L., and Barklis, E. (2009). HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4, 5)-bisphosphate. Virology 387, 466-472.
4. Alfadhli, A., Still, A., and Barklis, E. (2009). Analysis of human immunodeficiency virus type 1 matrixbind-ing to membranes and nucleic acids. J. Virol. 83, 12196-12203.
5. Alfadhli, A., Huseby, D., Kapit, E., Col-man, D., and Barklis, E. (2007). Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer. J. Virol. 81, 1472-1478.
6. Alfadhli, A., McNett, H., Tsagli, S., Bächinger, H. P., Peyton, D. H., and Barklis, E. (2011).HIV-1 matrix protein binding to RNA. J. Mol. Biol. 410, 653-666.
7. Aloia, R. C., Tian, H., and Jensen, F. C. (1993). Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc. Natl. Acad. Sci. U.S.A. 90, 5181-5185.
8. Arthur, L. O., Bess, J. W. Jr., Sowder, R. C. I., Benveniste, R. E., Mann, D. L., Chermann, J.-C., and Henderson, L. E. (1992). Cellular proteins bound to immunodeficiency virus: implications for pathogenesis and vaccines. Science 258, 1935-1938.
9. Batonick, M., Favre, M., Boge, M., Spearman, P., Höning, S., and Thali, M. (2005). Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2. Virology 342, 190-200.
10. Behnia, R., and Munro, S. (2005). Organelle identity and the signposts for membrane traffic. Nature 438, 597-604.
11. Berlioz-Torrent, C., Shacklett, B. L., Erdtmann, L., Delamarre, L., Bouchaert, I., Sonigo, P., Dokhelar, M. C., and Benarous, R. (1999). Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intra-cellular and cell surface expression of envelope glycoproteins. J. Virol. 73, 1350-1361.
12. Boehm, M., andBonifacino, J. S. (2002). Genetic analyses of adaptin function from yeast to mammals. Gene 286, 175-186.
13. Boge, M., Wyss, S., Bonifacino, J. S., and Thali, M. (1998). A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor. J. Biol. Chem. 273, 15773-15778.
14. Bouamr, F., Scarlata, S., and Carter, C. A. (2003). Role of myristylation in HIV-1 Gag assembly. Biochemistry 42, 6408-6417.
15. Brandano, L., and Stevenson, M. (2012). A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles. J. Virol. 86, 2347-2359.
16. Brass, A. L., Dykxhoorn, D. M., Benita, Y., Yan, N., Engelman, A., Xavier, R. J., Lieberman, J., and Elledge, S. J. (2008). Identification of host proteins required for HIV infection through a functional genomic screen. Science 319, 921-926.
17. Braunewell, K. H., and Gundelfinger, E. D. (1999). Intracellular neuronal calcium sensor proteins: a family of EF-hand calcium-binding proteins in search of a function. Cell Tissue Res. 295, 1-12.
18. Briggs, J. A. G., and Kräusslich, H.-G. (2011). The molecular architecture of HIV. J. Mol. Biol. 410, 491-500.
19. Briggs, J. A. G., Riches, J. D., Glass, B., Bartonova, V., Zanetti, G., and Kräusslich, H.-G. (2009). Structure and assembly of immature HIV. Proc. Natl. Acad. Sci. U.S.A. 106, 11090-11095.
20. Brown, D. A., and London, E. (1997). Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes? Biochem. Biophys. Res. Commun. 240, 1-7.
21. Brown, D. A., and London, E. (1998). Structure and origin of ordered lipid domains in biological membranes. J. Membr. Biol. 164, 103-114.
22. Brown, D. A., and London, E. (2000). Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275, 17221-17224.
23. Bryant, M., and Ratner, L. (1990). Myristoylation-dependent replication and assembly of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. U.S.A. 87, 523-527.
24. Burniston, M. T., Cimarelli, A., Col-gan, J., Curtis, S. P., and Luban, J. (1999). Human immunodeficiency virus type 1 Gag polyprotein multi-merization requires the nucleocap-sid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein. J. Virol. 73, 8527-8540.
25. Byland, R., Vance, P. J., Hoxie, J. A., and Marsh, M. (2007). A conserved dileucine motif mediates clathrin and AP-2-dependent endocytosis of the HIV-1 envelope protein. Mol. Biol. Cell 18, 414-425.
26. Cai, M., Huang, Y., Craigie, R., and Clore, G. M. (2010). Structural basis of the association of HIV-1 matrix protein with DNA. PLoS ONE 5, e15675. doi:10.1371/jour-nal.pone.0015675
27. Campbell, S., Fisher, R. J., Towler, E. M., Fox, S., Issaq, H. J., Wolfe, T., Phillips, L. R., and Rein, A. (2001a). Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc. Natl. Acad. Sci. U.S.A. 98, 10875-10879.
28. Campbell, S. M., Crowe, S. M., and Mak, J. (200 1b). Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J. Clin. Virol. 22, 217-227.
29. Campbell, S., and Rein, A. (1999). In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J. Virol. 73, 2270-2279.
30. Camus, G., Segura-Morales, C., Molle, D., Lopez-Vergès, S., Begon-Pescia, C., Cazevieille, C., Schu, P., Bertrand, E., Berlioz-Torrent, C., and Basyuk, E. (2007). The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding. Mol. Biol. Cell 18, 3193-3203.
31. Chan, J., Dick, R. A., and Vogt, V. M. (2011). Rous sarcoma virus Gag has no specific requirement for phosphatidylinositol-(4, 5)-bisphosphate for plasma membrane association in vivo or for liposome interaction in vitro. J. Virol. 85, 10851-10860.
32. Chan, R., Uchil, P. D., Jin, J., Shui, G., Ott, D. E., Mothes, W., and Wenk, M. R. (2008). Retroviruses human immunodeficiency virus and murine leukemia virus are enriched in phosphoinositides. J. Virol. 82, 11228-11238.
33. Chattopadhyaya, R., Meador, W. E., Means, A. R., and Quiocho, F. A. (1992). Calmodulin structure refined at 1.7 Å resolution. J. Mol. Biol. 228, 1177-1192.
34. Checkley, M. A., Luttge, B. G., and Freed, E. O. (2011). HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation. J. Mol. Biol. 410, 582-608.
35. Chen, K., Bachtiar, I., Piszczek, G., Bouamr, F., Carter, C., and Tjan-dra, N. (2008). Solution NMR characterization of oligomerization and dynamics of equine infectious anemia virus matrix protein and its interaction with PIP2. Biochemistry 47, 1928-1937.
36. Chin, D., and Means, A. R. (2000). Calmodulin: a prototypical calcium sensor. Trends Cell Biol. 10, 322-328.
37. Chow, J. Y. H., Jeffries, C. M., Kwan, A. H., Guss, J. M., and Trewhella, J. (2010). Calmodulin disrupts the structure of the HIV-1 MA protein. J.Mol. Biol. 400, 702-714.
38. Chu, H., Wang, J. J., and Spearman, P. (2010). Human immunodeficiency virus type-1 Gag and host vesicular trafficking pathways. Curr. Top. Microbiol. Immunol. 339, 67-84.
39. Chukkapalli, V., Hogue, I. B., Boyko, V., Hu, W.-S., andOno, A. (2008).Interaction between HIV-1 Gag matrix domain and phosphatidylinositol-(4, 5)-bisphosphate is essential for efficient Gag-membrane binding. J. Virol. 82, 2405-2417.
40. Chukkapalli, V., Oh, S. J., and Ono, A. (2010). Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain. Proc. Natl. Acad. Sci. U.S.A. 107, 1600-1605.
41. Chukkapalli, V., and Ono, A. (2011). Molecular determinants that regulate plasma membrane association of HIV-1 Gag. J. AM. Biol. 410, 512-524.
42. Cimarelli, A., Sandin, S., Hoglund, S., and Luban, J. (2000). Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA. J. Virol. 74, 3046-3057.
43. Cooper, J., Liu, L., Woodruff, E. A., Taylor, H. E., Goodwin, J. S., D'Aquila, R. T., Spearman, P., Hildreth, J. E. K., and Dong, X. (2011). Filamin A protein interacts with human immunodeficiency virus type 1 Gag protein and contributes to productive particle assembly. J. Biol. Chem. 286, 28498-28510.
44. Crist, R. M., Datta, S. A. K., Stephen, A. G., Soheilian, F., Mirro, J., Fisher, R. J., Nagashima, K., and Rein, A. (2009). Assembly properties of human immunodeficiency virus type 1 Gag-leucine zipper chimeras: implications for retrovirus assembly. J. Virol. 83, 2216-2225.
45. Dalton, A. K., Ako-Adjei, D., Murray, P. S., Murray, D., and Vogt, M. V (2007). Electrostatic interactions drive membrane association of the human immunodeficiency virus type 1 Gag MA domain. J. Virol. 81, 6434-6445.
46. Dalton, A. K., Murray, P. S., Murray, D., and Vogt, V M. (2005). Biochemical characterization of Rous sarcoma virus MA protein interaction with membranes. J. Virol. 79, 6227-6238.
47. Darlix, J. L., and Spahr, P. F. (1982). Binding sites of viral protein P19 onto Rous sarcoma virus RNA and possible controls of viral functions. J. Mol. Biol. 160, 147-161.
48. Datta, S. A. K., Curtis, J. E., Ratcliff, W., Clark, P. K., Crist, R. M., Lebowitz, J., Krueger, S., and Rein, A. (2007). Conformation of the HIV-1 Gag protein in solution. J. Mol. Biol. 365, 812-824.
49. Datta, S. A. K., Zhao, Z., Clark, P. K., Tarasov, S., Alexandratos, J. N., Campbell, S. J., Kvaratskhelia, M., Lebowitz, J., and Rein, A. (2007). Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J. Mol. Biol. 365, 799-811.
50. Davis, M. R., Jiang, J., Zhou, J., Freed, E. O., andAiken, C. (2006).Amutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41. J. Virol. 80, 2405-2417.
51. Dawson, L., and Yu, X. F. (1998). The role of nucleocapsid of HIV-1 in virus assembly. Virology 251, 141-157.
52. Ding, L., Derdowski, A., Wang, J.-J., and Spearman, P. (2003). Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts. J. Virol. 77, 1916-1926.
53. Dong, X., Li, H., Derdowski, A., Ding, L., Burnett, A., Chen, X., Peters, T. R., Dermody, T. S., Woodruff, E., Wang, J.-J., and Spearman, P. (2005). AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly. Cell 120, 663-674.
54. Dorfman, T., Mammano, F., Hasel-tine, W. A., and Göttlinger, H. G. (1994). Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68, 1689-1696.
55. Dou, J., Wang, J.-J., Chen, X., Li, H., Ding, L., and Spearman, P. (2009). Characterization of a myristoylated, monomeric HIV Gag protein. Virology 387, 341-352.
56. Edgcomb, S. P., and Murphy, K. P. (2002). Variability in the pKa of histidine side-chains correlates with burial within proteins. Proteins 49, 1-6.
57. Engeland, C. E., Oberwinkler, H., Schümann, M., Krause, E., Müller, G. A., and Kräusslich, H.-G. (2011). The cellular protein lyric interacts with HIV-1 Gag. J. Virol. 85, 13322-13332.
58. Erdie, C. R., and Wills, J. W (1990). Myristoylation of Rous sarcoma virus Gag protein does not prevent replication in avian cells. J. Virol. 64, 5204-5208.
59. Fallon, J. L., and Quiocho, F. A. (2003). A closed compact structure of native Ca+ 2-calmodulin. Structure 11, 1303-1307.
60. Faurobert, E., Chen, C.-K., Hurley, J. B., and Teng, D. H.-F. (1996). Drosophila neurocalcin, a fatty acy-lated, Ca-binding protein that associates with membranes and inhibits in vitro phosphorylation of bovine rhodopsin. J. Biol. Chem. 271, 10256-10262.
61. Fernandes, F., Chen, K., Ehrlich, L. S., Jin, J., Chen, M. H., Medina, G. N., Symons, M., Montelaro, R., Donaldson, J., Tjandra, N., and Carter, C. A. (2011). Phosphoinositides direct equine infectious anemia virus Gag trafficking and release. Traffic 12, 438-451.
62. Finn, B. E., Evenäs, J., Drakenberg, T., Waltho, J. P., Thulin, E., and Forsén, S. (1995). Calcium-induced structural changes and domain autonomy in calmodulin. Nat. Struct. Biol. 2, 777-783.
63. Finzi, A., Orthwein, A., Mercier, J., and Cohen, E. A. (2007). Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane. J. Virol. 81, 7476-7490.
64. Fledderman, E. L., Fujii, K., Ghanam, R. H., Waki, K., Prevelige, P. E., Freed, E. O., and Saad, J. S. (2010). Myristate exposure in the HIV-1 matrix protein is modulated by ph. Biochemistry 49, 9551-9562.
65. Freed, E. O., and Martin, A. M. (1996). Domains of the human immonode-ficiency virus type 1 matrix andgp41 cytoplasmic tail required for envelope incorporation into virions. J. Virol. 70, 341-351.
66. Freed, E. O., Orenstein, J. M., Buckler-White, A. J., and Martin, M. A. (1994). Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production.J. Virol. 68, 5311-5320.
67. Freed, O. E., and Martin, A. M. (1995). Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J. Virol. 69, 1984-1989.
68. Ganser-Pornillos, B. K., Cheng, A., and Yeager, M. (2007). Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell 131, 70-79.
69. Ganser-Pornillos, B. K., Yeager, M., and Sundquist, W. I. (2008). The structural biology of HIV assembly. Curr. Opin. Struct. Biol. 18, 203-217.
70. Ghanam, R. H., Fernandez, T. F., Fledderman, E. L., and Saad, J. S. (2010). Binding of calmodulin to the HIV-1 matrix protein triggers myristate exposure. J. Biol. Chem. 285, 41911-41920.
71. Gheysen, D., Jacobs, E., De Foresta, F., Thiriart, C., Francotte, M., Thines, D., and De Wilde, M. (1989). Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells. Cell 59, 103-112.
72. Golub, T., and Caroni, P. (2005). PI(4, 5)P2-dependent microdomain assemblies capture microtubules to promote and control leading edge motility. J. Cell Biol. 169, 151-162.
73. Gottlieb, R. A., Giesing, H. A., Zhu, J. Y., Engler, R. L., and Babior, B. M. (1995). Cell acidification in apopto-sis: granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H+-ATPase. Proc. Natl. Acad. Sci. U.S.A. 92, 5965-5968.
74. Gousset, K., Ablan, S. D., Coren, L. V., Ono, A., Soheilian, F., Nagashima, K., Ott, D. E., and Freed, E. O. (2008). Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog. 4, e1000015. doi:10.1371/journal.ppat.1000015
75. Greene, W C, Debyser, Z., Ikeda, Y., Freed, E. O., Stephens, E., Yonemoto, W., Buckheit, R. W., Esté, J. A., and Cihlar, T. (2008). Novel targets for HIV therapy. Antiviral Res. 80, 251-265.
76. Grigorov, B., Arcanger, F., Roingeard, P., Darlix, J. L., and Muriaux, D. (2006). Assembly of infectious HIV-1 in human epithelial and T-lymphoblastic cell lines. J. Mol. Biol. 359, 848-862.
77. Hamard-Peron, E., Juilliard, F., Saad, J. S., Roy, C., Roingeard, P., Summers, M. F., Darlix, J. L., Picart, C., and Muriaux, D. (2010). Targeting of MuLV Gag to the plasma membrane is mediated by PI(4, 5)P2/PS and a polybasic region in the Matrix. J. Virol. 84, 503-515.
78. Hamard-Peron, E., and Muriaux, D. (2011). Retroviral matrix and lipids, the intimate interactions. Retrovirol-ogy 8, 15.
79. Hayashi, N., Matsubara, M., Jinbo, Y., Titani, K., Izumi, Y., and Mat-sushima, N. (2002). Nef of HIV-1 interacts directly with calcium-bound calmodulin. Protein Sci. 11, 529-537.
80. Hearps, A. C., Wagstaff, K. M., Piller, S. C., and Jans, D. A. (2008). The N-terminal basic domain of the HIV-f matrix protein does not contain a conventional nuclear localization sequence but is required for DNA binding and protein self-association. Biochemistry 47, 2199-2210.
81. Hermida-Matsumoto, L., and Resh, M. D. (1999). Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding fo Pr55gag and p17MA.J. Virol. 73, 1902-1908.
82. Hermida-Matsumoto, L., and Resh, M. D. (2000). Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imagine. J. Virol. 74, 8670-8679.
83. Hoeflich, K. P., and Ikura, M. (2002). Calmodulin in action: diversity in target recognition and activation mechanisms. Cell 108, 739-742.
84. Hogue, I. B., Hoppe, A., and Ono, A. (2009). Quantitative FRET microscopy analysis of HIV-1 Gag-Gag interaction: the relative contributions of CA and NC domains, and membrane binding. J. Virol. 83, 7322-7336.
85. Holm, K., Weclewicz, K., Hewson, R., and Suomalainen, M. (2003). Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55gag associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. J. Virol. 77, 4805-4817.
86. Inlora, J., Chukkapalli, V., Derse, D., and Ono, A. (2011). Gag localization and virus-like particle release mediated by the matrix domain of human T-lymphotropic virus type 1 Gag are less dependent on phosphatidylinositol-(4, 5)-bisphosphate than those mediated by the matrix domain of HIV-1 Gag. J. Virol. 85, 3802-3810.
87. Ishida, H., and Vogel, H. J. (2006). Protein-peptide interaction studies demonstrate the versatility of calmodulin target protein binding. Protein Pept. Lett. 13, 455-465.
88. Izumi, Y., Watanabe, H., Watanabe, N., Aoyama, A., Jinbo, J., and Hayashi, N. (2008). Solution X-ray scattering reveals a novel structure of calmodulin complexed with a binding domain peptide from the HIV-1 matrix protein p17. Biochemistry 47, 7158-7166.
89. Jäger, S., Cimermancic, P., Gulbahce, N., Johnson, J. R., McGovern, K. E., Clarke, S. C., Shales, M., Mercenne, G., Pache, L., Li, K., Hernandez, H., Jang, G. M., Roth, S. L., Akiva, E., Marlett, J., Stephens, M., D'Orso, I., Fernandes, J., Fahey, M., Mahon, C., O'Donoghue, A. J., Todorovic, A., Morris, J. H., Maltby, D A., Alber, T., Cagney, G., Bush man, F. D., Young, J. A., Chanda, S. K., Sundquist, W. I., Kortemme, T., Hernandez, R. D., Craik, C. S., Burlingame, A., Sali, A., Frankel, A. D., and Krogan, N. J. (2011). Global landscape of HIV-human protein complexes. Nature 481, 365-370.
90. Janmey, P. A., Iida, K., Yin, H. L., and Stossel, T. P. (1987). Polyphosphoinositide micelles and polyphosphoinositi de-containing vesicles dissociate endogenous gelsolin-actin complexes and promote actin assembly from the fast-growing end of actin filaments blocked by gelsolin. J. Biol. Chem. 262, 12228-12236.
91. Joshi, A., Ablan, S. D., Soheilian, E, Nagashima, K., and Freed, E. O. (2009a). Evidence that produc tive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment. J. Virol. 83, 5375-5387.
92. Joshi, A., Nagashima, K., and Freed, E. O. (2009). Defects in cellular sorting and retroviral assembly induced by GGA overexpression. BMC Cell Biol. 10, 72. doi:10.1186/ 1471-2121-10-72
93. Joshi, A., Garg, H., Ablan, S. D., and Freed, E. O. (2011). Evidence of a role for soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) machinery in HIV-1 assembly and release. J. Biol. Chem. 286, 29861-28971.
94. Joshi, A., Garg, H., Nagashima, K., Boni-facino, J. S., and Freed, E. O. (2008). GGA and Arf proteins modulate retrovirus assembly and release. Mol. Cell 30, 227-238.
95. Joshi, A., Nagashima, K., and Freed, E. O. (2006). Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, Gag-Gag interactions, Gag-membrane binding, and virion maturation. J. Virol. 80, 7939-7951.
96. Jouvenet, N., Bieniasz, P. D., and Simon, S. M. (2008). Imaging the biogenesis of individual HIV-1 virions in live cells. Nature 454, 236-240.
97. Jouvenet, N., Neil, S. J. D., Bess, C., Johnson, M. C., Virgen, C. A., Simon, S. M., and Bieniasz, P. D. (2006). Plasma membrane is the site of productive HIV-1 particle assembly. PLoSBiol. 4, e435. doi:10.1371/jour-nal.pbio.0040435
98. Katoh, I., Kyushiki, H., Sakamoto, Y., Ikawa, Y., and Yoshinaka, Y. (1991). Bovine leukemia virus matrix-associated protein MA(p15): further processing and formation of a specific complex with the dimer of the 5'-terminal genomic rna fragment. J. Virol. 65, 6845-6855.
99. Kinnunen, P. K., Kõiv, A., Lehtonen, J. Y., Rytömaa, M., and Mustonen, P. (1994). Lipid dynamics and peripheral interactions of proteins with membrane surfaces. Chem. Phys. Lipids 73, 181-207.
100. König, R., Zhou, Y., Elleder, D., Diamond, T. L., Bonamy, G. M. C., Ire-lan, J. T., Chiang, C.-Y., Tu, B. P., De Jesus, P. D., Lilley, C. E., Sei-del, S., Opaluch, A. M., Caldwell, J. S., Weitzman, M. D., Kuhen, K. L., Bandyopadhyay, S., Ideker, T., Orth, A. P., Miraglia, L. J., Bushman, F. D., Young, J. A., and Chanda, S. K. (2008). Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135, 49-60.
101. Leis, J. P., McGinnis, J., and Green, R. W. (1978). Rous sarcoma virus p19 binds to specific double-stranded regions of viral RNA: effect of p19 on cleavage of viral RNA by RNase III. Virology 84, 87-98.
102. Lever, A. M. L., and Jeang, K.-T. (2011). Insights into cellular factors that regulate HIV-1 replication in human cells. Biochemistry 50, 920-931.
103. Li, H., Dou, J., Ding, L., and Spearman, P. (2007). Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag mul-timerization in mammalian cells. J. Virol. 81, 12899-12910.
104. Li, S., Hill, C. P., Sundquist, W. I., and Finch, J. T. (2000). Image reconstructions of helical assemblies of the HIV-1 CA protein. Nature 407, 409-413.
105. Lindwasser, O. W., and Resh, M. D. (2001). Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J. Virol. 75, 7913-7924.
106. Lindwasser, O. W., and Resh, M. D. (2002). Myristoylation as a target for inhibiting HIV assembly: unsat-urated fatty acids block viral budding. Proc. Natl. Acad. Sci. U.S.A. 99, 13037-13042.
107. Liu, T., Ryan, M., Dahlquist, F. W., and Griffith, O. H. (1997). Determination of pKa values of the histidine side chains of phosphatidylinositol-specific phospholipase C from Bacillus cereus by NMR spectroscopy and site-directed mutagenesis. Protein Sci. 6, 1937-1944.
108. Lodge, R., Gottlinger, H., Gabuzda, D., Cohen, E. A., and Lemay, G. (1994). The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J. Virol. 68, 4857-4861.
109. Lopez-Vergès, S., Camus, G., Blot, G., Beauvoir, R., Benarous, R., and Berlioz-Torrent, C. (2006). Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions. Proc. Natl. Acad. Sci. U.S.A. 103, 14947-14952.
110. Lusso, P., Di Marzo Veronese, F., Ensoli, B., Franchini, G., Jemma, C., Derocco, S. E., Kalyanaraman, V S., and Gallo, R. C. (1990). Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses. Science 247, 848-852.
111. Makutonina, A., Voss, T. G., Plymale, D. R., Fermin, C. D., Norris, C. H., Vigh, S., and Garry, R. F. (1996). Human immunodeficiency virus infection of T-lymphoblastoid cells reduces intracellular pH. J. Virol. 70, 7049-7055.
112. Mammano, F., Kondo, E., Sodroski, J., Bukovsky, A., and Gottlinger, H. G. (1995). Rescue of human immunodeficiency virus type I matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J. Virol. 69, 3824-3830.
113. Matsubara, M., Jing, T., Kawamura, K., Shimojo, N., Titani, K., Hashimoto, K., and Hayashi, N. (2005). Myristoyl moiety of HIV Nef is involved in regulation of the interaction with calmodulin in vivo. Protein Sci. 14, 494-503.
114. Matsubara, M., Nakatsu, T., Kato, H., and Taniguchi, H. (2004). Crystal structure of a myristoylated CAP-23/NAP-22 N-terminal domain complexed with Ca2+/calmodulin. EMBO J.23, 712-718.
115. Matsubara, M., Titani, K., Taniguchi, H., and Hayashi, N. (2003). Direct involvement of protein myristoylation in myristoylated alanine-rich C kinase substrate (MARCKS)-calmodulin interaction. J. Biol. Chem. 278, 48898-48902.
116. Matsuda, S., Hisatomi, O., Ishino, T., Kobayashi, Y., and Tokunaga, F. (1998). The role of calcium-binding sites in S-modulin function. J. Biol. Chem. 273, 20223-20227.
117. McLaughlin, S., and Murray, D. (2005). Plasma membrane phosphoinosi-tide organization by protein electrostatics. Nature 438, 605-611.
118. Melkonian, K. A., Ostermeyer, A. G., Chen, J. Z., Roth, M. G., and Brown, D. A. (1999). Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. J. Biol Chem. 274, 3910-3917.
119. Méric, C., and Spahr, P.-F. (1986). Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging. J. Virol. 60, 450-459.
120. Micoli, K. J., Mamaeva, O., Piller, S. C., Barker, J. L., Pan, G., Hunter, E., and McDonald, J.M. (2006).Pointmuta-tions in the C-terminus of HIV-1 gp 160 reduce apoptosis and calmod-ulin binding without affecting viral replication. Virology 344, 468-479.
121. Moolenaar, W. H., Tsien, R. Y., Van Der Saag, P. T., and De Laat, S. W. (1983). Na+/H+ exchange and cytoplasmic pH in the action of growth factors in human fibroblasts. Nature 304, 645-648.
122. Morikawa, Y., Hockley, D. J., Nermut, M. V., and Jones, I. M. (2000). Roles of matrix, p2, and N-terminal myris-toylation in human immunodeficiency virus type 1 Gag assembly. J. Virol. 74, 16-23.
123. Morikawa, Y., Zhang, W.-H., Hockley, D. J., Nermut, M. V., and Jones, I. M. (1998). Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17. J. Virol. 72, 7659-7663.
124. Murakami, T., and Freed, E. O. (2000). The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope gly-coprotein incorporation into viri-ons. Proc. Natl. Acad. Sci. U.S.A. 97, 343-348.
125. Muriaux, D., Mirro, J., Harvin, D., and Rein, A. (2001). RNA is a structural element in retrovirus particles. Proc. Natl. Acad. Sci. U.S.A. 98, 5246-5251.
126. Nakatsu, F., and Ohno, H. (2003). Adaptor protein complexes as the key regulators of protein sorting in the post-Golgi network. Cell Struct. Funct. 28, 419-429.
127. Narazaki, M., Fujimoto, M., Mat-sumoto, T., Morita, Y., Saito, H., Kajita, T., Yoshizaki, K., Naka, T., and Kishimoto, T. (1998). Three distinct domains of SSI-1/SOCS-1/JAB protein are required for its suppression of interleukin 6 signaling. Proc. Natl. Acad. Sci. U.S.A. 95, 13130-13134.
128. Nguyen, D. G., Booth, A., Gould, S. J., and Hildreth, J. E. (2003). Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J. Biol. Chem. 278, 52347-52354.
129. Nguyen, D. H., and Hildreth, J. E. (2000). Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts. J. Virol. 74, 3264-3272.
130. Nishi, M., Ryo, A., Tsurutani, N., Ohba, K., Sawasaki, T., Morishita, R., Per-rem, K., Aoki, I., Morikawa, Y., and Yamamoto, N. (2009). Requirement for microtubule integrity in the SOCS1-mediated intracellular dynamics of HIV-1 Gag. FEBS Lett. 583, 1243-1250.
131. Nydegger, S., Foti, M., Derdowski, A., Spearman, P., and Thali, M. (2003). HIV-1 egress is gated through late endosomal membranes. Traffic 4, 902-910.
132. Ohno, H., Aguilar, R. C., Fournier, M. C., Hennecke, S., Cosson, P., and Boni-facino, J. S. (1997). Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family. Virology 238, 305-315.
133. Ono, A. (2009). HIV-1 assembly at the plasma membrane: Gag trafficking and localization. Future Virol. 4, 241-257.
134. Ono, A. (2010). Relationships between plasma membrane microdomains and HIV-1 assembly. Biol. Cell 102, 335-350.
135. Ono, A., Ablan, S. D., Lockett, S. J., Nagashima, K., and Freed, E. O. (2004). Phosphatidylinositol (4, 5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane. Proc. Natl. Acad. Sci. U.S.A. 101, 14889-14894.
136. Ono, A., Demirov, D., and Freed, E. O. (2000). Relationship between human immunodeficiency virus type-1 Gag multimerization and membrane binding. J. Virol. 74, 5142-5150.
137. Ono, A., Orenstein, J. M., and Freed, E. O. (2000). Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. J. Virol. 74, 2855-2866.
138. Ono, A., and Freed, E. O. (1999). Binding of human immunodeficiency virus type 1 Gag to membrane: role of the matrix amino terminus. J. Virol. 73, 4136-4144.
139. Ono, A., and Freed, E. O. (2001). Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. U.S.A. 98, 13925-13930.
140. Ono, A., and Freed, E. O. (2004). Cell-type-dependent tageting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body. J. Virol. 78, 1552-1563.
141. Ono, A., and Freed, E. O. (2005). Role of lipid rafts in virus replication. Adv. Virus Res. 64, 311-358.
142. Ono, A., Huang, M., and Freed, E. O. (1997). Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions. J. Virol. 71, 4409-4418.
143. Osawa, M., Tokumitsu, H., Swindells, M. B., Kurihara, H., Orita, M., Shibanuma, T., Furuya, T., and Ikura, M. (1999). A novel target recognition revealed by calmodulin in complex with Ca2+ -calmodulin-dependent kinase kinase. Nat. Struct. Biol. 6, 819-824.
144. Ott, D. E. (2008). Cellular proteins detected in HIV-1. Rev. Med. Virol. 18, 159-175.
145. Ott, D. E., Coren, L. V., and Gagliardi, T. D. (2005). Redundant roles for nucleocapsid and matrix RNA-binding sequences in human immunodeficiency virus type 1 assembly.J. Virol. 79, 13839-13847.
146. Owens, R. J., and Compans, R. W. (1989). Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolat-eral surfaces of polarized epithelial cells. J. Virol. 63, 978-982.
147. Owens, R. J., Dubay, J. W., Hunter, E., and Compans, R.W. (1991). Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc. Natl. Acad. Sci. U.S.A. 88, 3987-3991.
148. Paillart, J.-C., and Gottlinger, H. G. (1999). Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of Gag membrane targeting. J. Virol. 73, 2604-2612.
149. Parent, L. J., and Gudleski, N. (2011). Beyond plasma membrane targeting: role of the MA domain of Gag in retroviral genome encapsidation. J.Mol. Biol. 410, 553-564.
150. Pelchen-Matthews, A., Krameer, B., and Marsh, M. (2003). Infectious HIV-1 assembles in late endosomes in primary macrophages. J. Cell Biol. 162, 443-445.
151. Provitera, P., Bouamr, F., Murray, D., Carter, C., and Scarlata, S. (2000). Binding of equine infectious anemia virus matrix protein to membrane bilayers involves multiple interactions. J. Mol. Biol. 296, 887-898.
152. Purohit, P., Dupont, S., Stevenson, M., and Green, M. R. (2001). Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection. RNA 7, 576-584.
153. Radding, W., Pan, Z. Q., Hunter, E., Johnston, P., Williams, J. P., and McDonald, J. M. (1996). Expression of HIV-1 envelope glycoprotein alters cellular calmodulin. Biochem. Biophys. Res. Commun. 218, 192-197.
154. Radding, W., Williams, J. P., McKenna, M. A., Tummala, R., Hunter, E., Tytler, E. M., and McDonald, J. M. (2000). Calmodulin andHIVtype 1: interactions with Gag and Gag products. AIDS Res. Hum. Retroviruses 16, 1519-1525.
155. Ramalingam, D., Duclair, S., Datta, S. A., Ellington, A., Rein, A., and Prasad, V R. (2011). RNAaptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains andinhibit virus production. J.Virol. 85, 305-314.
156. Reil, H., Bukovsky, A. A., Gelderblom, H. R., and Gottlinger, H. G. (1998). Efficient HIV-1 replication can occur in the absence of the viral matrix protein. EMBO J. 17, 2699-2708.
157. Robinson, M. S., and Bonifacino, J. S. (2001). Adaptor-related proteins. Curr. Opin. Cell Biol. 13, 444-453.
158. Rogers, M. S., and Strehler, E. E. (1996). Calmodulin-like proteins, " in Guidebook to the Calcium-Binding Proteins, eds M. R. Celio, T. Pauls, and B. Schwaller (Oxford: Oxford University Press), 34-40.
159. Ryo, A., Tsurutani, N., Obha, K., Kimura, R., Komano, J., Nishi, M., Soeda, H., Hattori, S., Perrem, K., Yamamoto, M., Chiba, J., Mimaya, J.-I., Yoshimura, K., Matsushita, S., Honda, M., Yoshimura, A., Sawasaki, T., Aoki, I., Morikawa, Y., and Yamamoto, N. (2008). SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag. Proc. Natl. Acad. Sci. U.S.A. 105, 294-299.
160. Rytömaa, M., and Kinnunen, P. K. (1995). Reversibility of the binding of cytochromec to liposomes. Implications for lipid-protein interactions. J. Biol. Chem. 270, 3197-3202.
161. Saad, J. S., Ablan, S. D., Ghanam, R. H., Kim, A., Andrews, K., Nagashima, K., Soheilian, F., Freed, E. O., and Summers, M. F. (2008). Structure of the myristylated HIV-2 MA protein and the role of phosphatidylinositol-(4, 5)-bisphosphate in membrane targeting. J. Mol. Biol. 382, 434-447.
162. Saad, J. S., Kim, A., Ghanam, R. H., Dal-ton, A.K., Vogt, M.V., Wu, Z., Lu, W., and Summers, M. F. (2007). Mutations that mimic phosphorylation of the HIV-1 matrix protein do not perturb the myristyl switch. Protein Sci. 16, 1793-1797.
163. Saad, J. S., Loeliger, E., Luncsford, P., Liriano, M., Tai, J., Kim, A., Miller, J., Joshi, A., Freed, E. O., and Summers, M. F. (2007). Point mutations in the HIV-1 matrix protein turn off the myristyl switch. J. Mol Biol. 366, 574-585.
164. Saad, J. S., Miller, J., Tai, J., Kim, A., Ghanam, R. H., and Summers, M. F. (2006). Structural basis for target-ingHIV-1 Gag to virus assembly sites on the plasma membrane. Proc. Natl. Acad. Sci. U.S.A. 103, 11364-11369.
165. Samal, A. B., Ghanam, R. H., Fernandez, T. F., Monroe, E. B., and Saad, J. S. (2011). NMR, biophysical and biochemical studies reveal the minimal calmodulin-binding domain of the HIV-1 matrix protein. J. Biol Chem. 286, 33533-33543.
166. Schuldiner, S., and Rozengurt, E. (1982). Na+/H+ antiport in Swiss 3T3 cells: mitogenic stimulation leads to cyto-plasmic alkalinization. Proc. Natl. Acad. Sci. U.S.A. 79, 7778-7782.
167. Sherer, N. M., Lehmann, M. J., Jimenez-Soto, L. F., Ingmundson, A., Horner, S. M., Cicchetti, G., Allen, P. G., Pypaert, M., Cunningham, J. M., and Mothes, W. (2003). Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4, 785-801.
168. Shkriabai, N., Datta, S. A., Zhao, Z., Hess, S., Rein, A., and Kvaratskhe-lia, M. (2006). Interactions of HIV-1 Gag with assembly cofactors. Biochemistry 45, 4077-4083.
169. Spearman, P., Horton, R., Ratner, L., and Kuli-Zade, I. (1997). Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J. Virol. 71, 6582-6592.
170. Srinivas, S. K., Srinivas, R. V., Anan-tharamaiah, G. M., Compans, R. W., and Segrest, J. P. (1993). Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. J. Biol Chem. 268, 22895-22899.
171. Stansell, E., Apkarian, R., Haubova, S., Diehl, W. E., Tytler, E. M., and Hunter, E. (2007). Basic residues in the Mason-Pfizer monkey virus Gag matrix domain regulate intracellu-lar trafficking and capsid-membraneinteractions. J. Virol. 81, 8977-8988.
172. Steeg, C. M., and Vogt, V M. (1990). RNA-binding properties of the matrixprotein (p19gag) ofaviansarcoma and leukemia viruses. J. Virol. 64, 847-855.
173. Strasner, A. B., Natarajan, M., Doman, T., Key, D., August, A., and Henderson, A. J. (2008). The Src kinase Lck facilitates assembly of HIV-1 at the plasma membrane. J. Immunol. 181, 3706-3713.
174. Tanaka, T., Ames, J. B., Harvey, T. S., Stryer, L., and Ikura, M. (1995). Sequestration of the membrane-targeting myristoyl group of recov-erin in the calcium-free state. Nature 376, 444-447.
175. Tang, C., Loeliger, E., Luncsford, P., Kinde, I., Beckett, D., and Summers, M. F. (2004). Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl Acad. Sci. U.S.A. 101, 517-522.
176. Thirkettle, H.J., Girling, J., Warren, A.Y., Mills, I. G., Sahadevan, K., Leung, H., Hamdy, F., Whitaker, H. C., andNeal, D. E. (2009). LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clin. Cancer Res. 15, 3003-3013.
177. Tomita, Y., Noda, T., Fujii, K., Watan-abe, T., Morikawa, Y., and Kawaoka, Y (2011). The cellular factors Vps 18 and Mon2 are required for efficient production of infectious HIV-1 particles. J. Virol. 85, 5618-5627.
178. Towler, D. A., Adams, S. P., Eubanks, S. R., Towery, D. S., Jackson-Machelski, E., Glaser, L., and Gordon, J. I. (1988). Myristyl CoA:protein N-myristoyltransferase activities from rat liver and yeast possess overlapping yet distinct peptide substrate specificities.J. Biol Chem. 263, 1784-1790.
179. Tuominen, E. K., Wallace, C. J., and Kin-nunen, P. K. (2002). Phospholipid-cytochrome c interaction: evidence for the extended lipid anchorage. J. Biol. Chem. 277, 8822-8826.
180. Turner, B. G., and Summers, M. F. (1999). Structural biology of HIV. J. Mol. Biol. 285, 1-32.
181. Valentine, K. G., Peterson, R., Saad, J. S., Summers, M. F., Xu, X., Ames, J. B., and Wand, A. J. (2010). Reverse micelle encapsulation of membrane anchored proteins for solution NMR studies. Structure 18, 9-16.
182. Vetter, S. W., and Leclerc, E. (2003). Novel aspects of calmodulin target recognition and activation. Eur. J. Biochem. 270, 404-414.
183. Waheed, A. A., and Freed, E. O. (2009). Lipids and membrane micro domains in HIV-1 replication. Virus Res. 143, 162-176.
184. Welsch, S., Keppler, O. T., Haber-mann, A., Allespach, I., Krijnse-Locker, J., and Kräusslich, H.-G. (2007). HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 3, e36.
185. Wilk, T., Pfeiffer, T., and Bosch, V. (1992). Retained in vitro infectiv-ity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product. Virology 189, 167-177.
186. Wright, E. R., Schooler, J. B., Ding, H. J., Kieffer, C., Fillmore, C., Sundquist, W I., and Jensen, G. J. (2007). Electron crytomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J.26, 2218-2226.
187. Wyss, S., Berlioz-Torrent, C., Boge, M., Blot, G., Höning, S., Benarous, R., and Thali, M. (2011). The highly conserved C-terminal dileucine motif in the cytosolic domain of the human immunodeficiency virus type 1 envelope glycoprotein is critical for its association with the AP-1 clathrin adaptor [correction of adapter]. J. Virol. 75, 2982-2992.
188. Yamniuk, A. P., and Vogel, H. J. (2004). Calmodulin's flexibility allows for promiscuity in its interactions with target proteins and peptides. Mol. Biotechnol. 27, 33-57.
189. Yap, K. L., Kim, J., Truong, K., Sherman, M., Yuan, T., and Ikura, M. (2000). Calmodulin target database. J. Struct. Funct. Genomics 1, 8-14.
190. Yoshimura, A., Naka, T., and Kubo, M. (2007). SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454-465.
191. Yu, X., Yuan, X., Matsuda, Z., Lee, T.-H., and Essex, M. (1992). The matrixprotein of human immunodeficiency virus type I is required for incorporation of viral envelope protein into mature virions. J. Virol. 66, 4966-4971.
192. Zacharias, D. A., Violin, J.D., Newton, A. C., andTsien, R. Y (2002). Partitioning of lipid-modified monomeric GFPs into membrane microdomains of live cells. Science 296, 913-916.
193. Zhou, H., Xu, M., Huang, Q., Gates, A. T., Zhang, X. D., Castle, J. C., Stec, E., Ferrer, M., Strulovici, B., Hazuda, D. J., and Espeseth, A. S. (2008). Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4, 495-504.
194. Zhou, W., Parent, L. J., Wills, J. W., and Resh, M. D. (1994). Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J. Virol. 68, 2556-2569.
195. Zhou, W., and Resh, M. D. (1996). Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J. Virol. 70, 8540-8548.